Share
Journal Information
Articles in press
Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info
Are corticosteroids safe in adolescent and adult patients with infectious mononucleosis? A retrospective cohort study
Emilio-Manuel Páez-Guillán, Joaquín Campos-Franco, Rosario Alende, Arturo González-Quintela
10.1016/j.eimc.2023.10.004
Available online 26 November 2023
Ictus, más allá del riesgo cardiovascular
Amaia Torrecilla Ugarte, Irene Díaz de Santiago, Rebeca Bermejo Garcés, Roberto Muñoz Arrondo
10.1016/j.eimc.2023.10.007
Available online 21 November 2023
Resultados de la encuesta nacional de REIV-TOXO sobre el cribado gestacional de la toxoplasmosis en España
Borja Guarch-Ibáñez, Clara Carreras-Abad, Maria Antoinette Frick, Daniel Blázquez-Gamero, Fernando Baquero-Artigao, Isabel Fuentes-Corripio, Pere Soler-Palacin
10.1016/j.eimc.2023.08.004
Available online 10 November 2023
The impact of the COVID-19 pandemic on healthcare services utilization among people living with HIV in Catalonia, Spain: A population-based cohort study
Yi-Hua Pan, Daniel K. Nomah, Marcos Montoro-Fernandez, Sergio Moreno-Fornés, Yesika Díaz, Jordi Aceitón, Andreu Bruguera, Josep M. Llibre, ... the PISCIS Cohort Study Group
10.1016/j.eimc.2023.09.001
Available online 23 October 2023
Utilidad predictiva de mortalidad de las escalas qSOFA, NEWS y GYM en el paciente anciano con infección en urgencias: estudio EDEN-5
Eric Jorge García-Lamberechts, Manuel Fuentes Ferrer, Cesáreo Fernández-Alonso, Guillermo Burillo-Putze, Sira Aguiló, Aitor Alquezar-Arbé, Francisco Javier Montero-Pérez, Javier Jacob, ... en representación de la red SIESTA
10.1016/j.eimc.2023.07.004
Open Article
Available online 19 October 2023
Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain
Sergio Serrano-Villar, José Moltó-Marhuenda, Marta Montero-Alonso, Cesar Diaz-Torné, María López-Cavanillas, Leopoldo Pérez de Isla
10.1016/j.eimc.2023.07.005
Open Article
Available online 16 October 2023
Spatial analysis for risk assessment of dengue in Spain
Beatriz Fernández-Martínez, Despina Pampaka, Pablo Suárez-Sánchez, Jordi Figuerola, Maria Jose Sierra, Inmaculada León-Gomez, Javier del Aguila, Diana Gómez-Barroso
10.1016/j.eimc.2023.06.010
Open Article
Available online 5 October 2023
Indirect impact of PCV10 children vaccination on the serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive disease in adults over 50 in Colombia, 2005–2019: Observational analysis
Carolina Duarte, Clara Inés Agudelo, Carlos Castañeda-Orjuela, Jaime Moreno, Olga Marina Sanabria, Adriana Bautista, Elizabeth Castañeda
10.1016/j.eimc.2023.07.002
Open Article
Available online 4 August 2023
Agreement between pharmacists and physicians on the assessment of appropriateness of antimicrobial prescribing
José María Gutiérrez-Urbón, Eva Campelo-Sánchez, Sara Cobo-Sacristán, Marcelo Domínguez-Cantero, María Victoria Gil-Navarro, Sonia Luque, María Eugenia Martínez-Núñez, Beatriz Mejuto, ... members of the Pharmaceutical Care Group for Patients with Infectious Diseases (AFinf) of the Spanish Society of Hospital Pharmacy (SEFH)
10.1016/j.eimc.2023.06.008
Open Article
Available online 3 August 2023
Recently acquired hepatitis C: Epidemiological characteristics and treatment response in a large cohort of MSM living with HIV in Madrid
Luz Martín-Carbonero, Ángela Gutierrez, Otilia Bisbal, Jorge Vergas, Alicia González-Baeza, Carmen Rodríguez Martín, María Jesús Vivancos, José Sanz, ... Pablo Ryan
10.1016/j.eimc.2023.06.011
Open Article
Available online 2 August 2023
Publish in
Enfermedades Infecciosas y Microbiología Clínica
Special content about COVID-19
- Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination
- Infección leve por SARS-CoV-2 en pacientes vulnerables: implantación de una vía clínica de tratamiento precoz
- Auritidibacter ignavus en muestras óticas de pacientes pediátricos. Presentación de 2 casos y revisión de la literatura
- Impact on tuberculosis diagnostic during COVID-19 pandemic in a tertiary care hospital
Free access articles
Enferm Infecc Microbiol Clin. 2024;42:102-7
Enferm Infecc Microbiol Clin. 2020;38:283-8
Enferm Infecc Microbiol Clin. 2021;39:262-4
La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:
SOCIOS PROTECTORES
-
- Pfizer GEP, S.L.U.
- Shionogi, S.L.U.
- AbbVie Spain, S.L.U.
- Gilead Sciences, S.L.U.
- Vircell Spain, S.L.U.
- Roche Diagnostics, S.L.U.
- ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
- Qiagen Iberia S.L.
- Laboratorios ViiV Healthcare, S.L.
SOCIOS PATROCINADORES
- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.
Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals